Thrombocytosis and venous thromboembolism in cancer patients with chemotherapy induced anemia may be related to ESA induced iron restricted erythropoiesis and reversed by administration of IV iron

No abstract is available for this paper.

• Publication year

  2012

• Venue

  American journal of hematology/oncology

• Publication date

  2012-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ajh.22262PMID 22262486
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients with chemotherapy-associated anemia.

  2011cited by this paper
• The relationship between serum hepcidin levels and clinical outcomes in patients with chemotherapy-associated anemia treated in a controlled trial.

  2011cited by this paper
• Detection, evaluation, and management of iron-restricted erythropoiesis.

  2010cited by this paper
• Parenteral iron therapy in cancer-associated anemia.

  2010cited by this paper
• Iron supplementation to treat anemia in patients with chronic kidney disease

  2010cited by this paper
• Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes

  2010cited by this paper
• Pooled analysis of individual patient-level data from all randomized, double-blind, placebo-controlled trials of darbepoetin alfa in the treatment of patients with chemotherapy-induced anemia.

  2009cited by this paper
• Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials.

  2009cited by this paper
• Anemia management in oncology and hematology.

  2009cited by this paper
• The anemia of inflammation/malignancy: mechanisms and management.

  2008cited by this paper
• Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia.

  2008cited by this paper
• Venous Thromboembolism Risk Model Predicts Early Progression and Overall Mortality in Cancer Patients Receiving Chemotherapy

  2008cited by this paper
• Should intravenous iron be the standard of care in oncology?

  2008cited by this paper
• Editorial Focus: Thrombosis with Erythropoietic Stimulating Agents—Does Iron‐Deficient Erythropoiesis Play a Role?

  2008cited by this paper
• Incident reporting and patient safety

  2007cited by this paper
• Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy.

  2007cited by this paper
• Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study.

  2007cited by this paper
• Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients.

  2006cited by this paper
• KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease.

  2006influential reference
• KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease.

  2006cited by this paper
• Risk factors for chemotherapy‐associated venous thromboembolism in a prospective observational study

  2005cited by this paper
• Cancer-Related Anemia: Pathogenesis, Prevalence and Treatment

  2005cited by this paper
• The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients.

  2004cited by this paper
• Iron Deficiency and Thrombosis: Literature Review

  2004cited by this paper
• Chemotherapy-induced anemia in adults: incidence and treatment.

  1999cited by this paper
• Effect of recombinant human erythropoietin on platelets in patients with anemia of renal failure: correlation of platelet count with erythropoietic activity and iron parameters

  1994cited by this paper

• Association of coagulation-related indicators with postoperative venous thromboembolism occurrence in patients with pituitary tumors

  2025influential citation
• Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Phase 3 Roxadustat Trials in Japan

  2024cites this paper
• Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Four Global Roxadustat Phase 3 Trials

  2024cites this paper
• Use of preoperative erythropoietin‐stimulating agents is associated with decreased thrombotic adverse events compared to red blood cell transfusion in surgical patients with anaemia

  2024cites this paper
• Will Prolyl Hydroxylase Inhibitors Supplant Erythropoiesis-Stimulating Agents and IV Iron in the Treatment of Chemotherapy-Induced Anemia?

  2024cites this paper
• Preoperative laboratory parameters associated with deep vein thrombosis in patients with ovarian cancer: retrospective analysis of 3,147 patients in a single institute

  2023cites this paper
• Synergistic immunotherapy targeting cancer-associated anemia: prospects of a combination strategy

  2023cites this paper
• Threshold of Serum Ferritin to Discriminate against Those at Greater Risk of Platelet Increase during Treatment with Hypoxia-Inducible Factor Prolyl Hydroxylase Domain Inhibitor

  2022cites this paper
• Development and validation of a predictive score for venous thromboembolism in newly diagnosed non-small cell lung cancer.

  2021cites this paper
• Association of Venous Thromboembolism and Early Mortality in Patients with Newly Diagnosed Metastatic Non-Small Cell Lung Cancer

  2021cites this paper
• Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, placebo‐controlled study (IRON‐CLAD)

  2021cites this paper
• Recognition of thrombotic risk of thrombocytosis in iron deficiency

  2021cites this paper
• Association of Venous Thromboembolism and Early Mortality in Patients with Newly Diagnosed Metastatic Non-Small Cell Lung Cancer

  2021cites this paper
• How I treat Cancer Anemia.

  2020cites this paper
• NIMO-CKD-UK: a real-world, observational study of iron isomaltoside in patients with iron deficiency anaemia and chronic kidney disease

  2020cites this paper
• Management of Perioperative Iron Deficiency in Cardiac Surgery: A Modified RAND Delphi Study.

  2020cites this paper
• A retrospective analysis of venous thromboembolism trends in chemotherapy‐induced anemia: Red blood cell transfusion versus erythrocyte stimulating agent administration

  2020cites this paper
• Iron deficiency induced thrombocytosis increases thrombotic tendency in rats.

  2020cites this paper
• Workup of anemia in cancer.

  2020cites this paper
• How I treat cancer-associated anemia

  2020cites this paper
• Efficiency and safety evaluation of prophylaxes for venous thrombosis after gynecological surgery

  2020cites this paper
• Efficacy and Safety of Supportive Care Biosimilars Among Cancer Patients: A Systematic Review and Meta-Analysis

  2019cites this paper
• Erythropoietin Therapy in Critically Ill and Acute Kidney Injury Patients

  2019cites this paper
• Iron in the biology and treatment of gastrointestinal cancer

  2019cites this paper
• Activin receptor ligand traps in chronic kidney disease

  2018cites this paper
• Khorana Score: Νew Predictor of Early Mortality in Patients With Lung Adenocarcinoma

  2018cites this paper
• Development of an Industrial Reference Sample for the Specific Activity of Erythropoietin

  2018cites this paper
• Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines†

  2018cites this paper
• Patterns of care in Jehovah's Witnesses patients with solid tumours and lymphoma

  2018cites this paper
• Chemotherapy-induced anemia: etiology, pathophysiology, and implications for contemporary practice

  2018cites this paper
• Feasibility of Intravenous Iron Isomaltoside to Improve Anemia and Quality of Life During Palliative Chemotherapy for Esophagogastric Adenocarcinoma

  2018cites this paper
• An international consensus statement on the management of postoperative anaemia after major surgical procedures

  2018cites this paper
• Rashomon Effect and the Contradiction of Data, Practice, and Regulations.

  2018cites this paper
• Association of Anemia with Venous Thromboembolism in Acutely Ill Hospitalized Patients: An APEX Trial Substudy.

  2018cites this paper
• Current misconceptions in diagnosis and management of iron deficiency.

  2017cites this paper
• Platelet count as a predictor of metastasis and venous thromboembolism in patients with cancer.

  2017cites this paper
• Position paper on management of iron deficiency in adult cancer patients

  2017cites this paper
• Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancer

  2017cites this paper
• ИССЛЕДОВАНИЕ МАТЕРИАЛОВ, РАЗРАБОТКА И ПРОИЗВОДСТВО СТАНДАРТНЫХ ОБРАЗЦОВ MATERIAL ANALYSIS, DEVELOPMENT AND PRODUCTION OF REFERENCE MATERIALS

  2016cites this paper
• Eisenmangel, Thrombozytose und Thromboembolie

  2016cites this paper
• The Impact of Lowering Haemoglobin Targets on Patterns of Erythropoiesis-Stimulating Agent Use in Patients on Haemodialysis

  2016cites this paper
• On both sides of the ocean.

  2016cites this paper
• Iron deficiency: a novel risk factor of recurrence in patients after unprovoked venous thromboembolism.

  2016cites this paper
• Regulation of platelet count by erythropoiesis-stimulating agents – iron axis in hemodialysis patients

  2016cites this paper
• A fast-track anaemia clinic in the Emergency Department: feasibility and efficacy of intravenous iron administration for treating sub-acute iron deficiency anaemia.

  2016cites this paper
• [Iron deficiency, thrombocytosis and thromboembolism].

  2016cites this paper
• Use of Hematopoietic Growth Factors and Risk of Thromboembolic and Pulmonary Toxicities in Elderly Patients with Advanced Ovarian Cancer.

  2016cites this paper
• Critical Role of Iron in Epoetin Alfa Treatment of Chemotherapy-Associated Anemia

  2016cites this paper
• Manejo preoperatorio de la anemia en cirugía oncológica

  2015cites this paper
• Algoritmo para el tratamiento de la anemia preoperatoria

  2015cites this paper
• Management of Iron Deficiency Anemia.

  2015cites this paper
• Forum for debate: Safety of allogeneic blood transfusion alternatives in the surgical/critically ill patient.

  2015cites this paper
• [Preoperative management of anemia in oncologic surgery].

  2015cites this paper
• [Algorithm for treating preoperative anemia].

  2015cites this paper
• Intravenous iron administration is associated with reduced platelet counts in patients with chronic kidney disease

  2015cites this paper
• Increased expression of HIF2α during iron deficiency–associated megakaryocytic differentiation

  2015cites this paper
• Forum for debate: Safety of allogeneic blood transfusion alternatives in the surgical/critically ill patient.

  2015cites this paper
• Target Hemoglobin May Be Achieved with Intravenous Iron Alone in Anemic Patients with Cardiorenal Syndrome: An Observational Study

  2015cites this paper
• Foro de debate: seguridad de las alternativas a la transfusión alogénica en el paciente quirúrgico y/o crítico

  2015cites this paper
• Implementing Patient Blood Management in major orthopaedic procedures: orthodoxy or pragmatism?

  2014cites this paper
• Ferric Carboxymaltose: A Review of Its Use in Iron Deficiency

  2014cites this paper
• RE: Adding epoetin alfa to intense dose-dense adjuvant chemotherapy for breast cancer: randomized clinical trial.

  2014cites this paper
• Costs of care for lung and colon cancer patients receiving chemotherapy following FDA policy changes

  2014cites this paper
• Perioperative anemia management in colorectal cancer patients: a pragmatic approach.

  2014cites this paper
• Should the ASCO/ASH Guidelines for the use of intravenous iron in cancer- and chemotherapy-induced anemia be updated?

  2014cites this paper
• Successful perioperative use of prothrombin complex concentrate in the treatment of acquired factor X deficiency in the setting of systemic light‐chain (AL) amyloidosis

  2014cites this paper
• Intravenous iron in chemotherapy‐induced anemia

  2014cites this paper
• Postsplenectomy Thromboembolic Risk in Children with Hematologic Disorders: Case Report

  2014cites this paper
• Randomized trial comparing ferric carboxymaltose vs oral ferrous glycine sulphate for postoperative anaemia after total knee arthroplasty.

  2014cites this paper
• RE: Adding Epoetin Alfa to Intense Dose-Dense Adjuvant Chemotherapy for Breast Cancer: Randomized Clinical Trial

  2014cites this paper
• Chapter 22 – Metals

  2014cites this paper
• Current Status of Use of Erythropoietic Agents in Cancer Patients

  2014cites this paper
• Adding Epoetin Alfa to Intense Dose-Dense Adjuvant Chemotherapy for Breast Cancer: Randomized Clinical Trial

  2013cites this paper
• Effects of Erythropoietin on Blood Vessels and the Heart

  2013cites this paper
• Bone Marrow Toxicity: Red Blood Cells

  2013cites this paper
• Adding Epoetin Alfa to Intense Dose-Dense Adjuvant Chemotherapy for Breast Cancer: Randomized Clinical Trial

  2013cites this paper
• Biomarkers for prediction of venous thromboembolism in cancer.

  2013cites this paper
• Physiology and Pharmacology of Erythropoietin

  2013cites this paper
• Intravenous iron supplementation for the treatment of chemotherapy-induced anaemia – systematic review and meta-analysis of randomised controlled trials

  2013cites this paper
• Current Management of Iron Deficiency Anemia in Inflammatory Bowel Diseases: A Practical Guide

  2013cites this paper
• Anaemia of chronic disease.

  2013cites this paper
• Impact of Erythropoietin on Intensive Care Unit Patients

  2013cites this paper
• Darbepoetin alfa in the treatment of anemia in cancer patients undergoing chemotherapy

  2012cites this paper
• Total dose iron dextran infusion in cancer patients: is it SaFe2+?

  2012cites this paper
• Update on safety of ESAs in cancer-induced anemia.

  2012cites this paper